Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 7081 AL 7095

[Sleep and wakefulness disorders in neurodegenerative diseases]

Yakovleva OV, Poluektov MG, Levin OS, Lyashenko EA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(4. Vyp. 2):83-91. doi: 10.17116/jnevro20181184283.

Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis in the Last Decade

Savelieff MG, Nam G, Kang J, Lee HJ, Lee M, Lim MH.

Chem Rev. 2019 Jan 23;119(2):1221-1322. doi: 10.1021/acs.chemrev.8b00138. Epub 2018 Aug 10.

Pharmacogenomics of Alzheimer's and Parkinson's diseases

Cacabelos R.

Neurosci Lett. 2020 May 1;726:133807. doi: 10.1016/j.neulet.2018.09.018. Epub 2018 Sep 17.

Neuroprotective Role of Phytochemicals

Velmurugan BK, Rathinasamy B, Lohanathan BP, Thiyagarajan V, Weng CF.

Molecules. 2018 Sep 27;23(10):2485. doi: 10.3390/molecules23102485.

Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration

Masaldan S, Bush AI, Devos D, Rolland AS, Moreau C.

Free Radic Biol Med. 2019 Mar;133:221-233. doi: 10.1016/j.freeradbiomed.2018.09.033. Epub 2018 Sep 25.

A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer's and Parkinson's diseases

Singh YP, Pandey A, Vishwakarma S, Modi G.

Mol Divers. 2019 May;23(2):509-526. doi: 10.1007/s11030-018-9878-4. Epub 2018 Oct 6.

Implications of Successful Symptomatic Treatment in Parkinson's Disease for Therapeutic Strategies of Alzheimer's Disease

Zhao L, Cheng X, Zhong C.

ACS Chem Neurosci. 2019 Feb 20;10(2):922-930. doi: 10.1021/acschemneuro.8b00450. Epub 2018 Dec 12.

Vitamin D basis of Alzheimer's disease: from genetics to biomarkers

Dursun E, Gezen-Ak D.

Hormones (Athens). 2019 Mar;18(1):7-15. doi: 10.1007/s42000-018-0086-5. Epub 2018 Nov 27.

Acute inability to mobilise resulting from probable donepezil-induced myoclonus

Whateley JM, Huffman AJ, Henderson EJ.

Age Ageing. 2018 Nov 1;47(6):907-908. doi: 10.1093/ageing/afy093.

Pharmacotherapeutic strategies for treating epilepsy in patients with Alzheimer's disease

Cretin B.

Expert Opin Pharmacother. 2018 Aug;19(11):1201-1209. doi: 10.1080/14656566.2018.1496237. Epub 2018 Jul 14.

CNS repurposing - Potential new uses for old drugs: Examples of screens for Alzheimer's disease, Parkinson's disease and spasticity

Parsons CG.

Neuropharmacology. 2019 Mar 15;147:4-10. doi: 10.1016/j.neuropharm.2018.08.027. Epub 2018 Aug 27.

A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease

Rahman SO, Singh RK, Hussain S, Akhtar M, Najmi AK.

Eur J Pharmacol. 2019 Jan 5;842:208-220. doi: 10.1016/j.ejphar.2018.10.040. Epub 2018 Oct 30.

Sleep disturbances increase the risk of dementia: A systematic review and meta-analysis

Shi L, Chen SJ, Ma MY, Bao YP, Han Y, Wang YM, Shi J, Vitiello MV, Lu L.

Sleep Med Rev. 2018 Aug;40:4-16. doi: 10.1016/j.smrv.2017.06.010. Epub 2017 Jul 6.

Meta-Analysis of Parkinson's Disease and Alzheimer's Disease Revealed Commonly Impaired Pathways and Dysregulation of NRF2-Dependent Genes

Wang Q, Li WX, Dai SX, Guo YC, Han FF, Zheng JJ, Li GH, Huang JF.

J Alzheimers Dis. 2017;56(4):1525-1539. doi: 10.3233/JAD-161032.

MicroRNAs, Aging, Cellular Senescence, and Alzheimer's Disease

Reddy PH, Williams J, Smith F, Bhatti JS, Kumar S, Vijayan M, Kandimalla R, Kuruva CS, Wang R, Manczak M, Yin X, Reddy AP.

Prog Mol Biol Transl Sci. 2017;146:127-171. doi: 10.1016/bs.pmbts.2016.12.009. Epub 2017 Feb 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias